Agenus Inc. (AGEN): Price and Financial Metrics
Agenus Inc. (AGEN)
Today's Latest Price: $4.08 USD
0.04 (0.99%)
Updated Oct 22 4:00pm
Add AGEN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AGEN Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for AGEN is -0.44 -- better than merely 6.46% of US stocks.
- Of note is the ratio of Agenus Inc's sales and general administrative expense to its total operating expenses; merely 11.84% of US stocks have a lower such ratio.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -0.83 for Agenus Inc; that's greater than it is for merely 6.24% of US stocks.
- Stocks that are quantitatively similar to AGEN, based on their financial statements, market capitalization, and price volatility, are PLX, ACIU, DNN, LOGC, and IPHA.
- Visit AGEN's SEC page to see the company's official filings. To visit the company's web site, go to agenusbio.com.
AGEN Stock Price Chart Interactive Chart >
AGEN Price/Volume Stats
| Current price | $4.08 | 52-week high | $5.63 |
| Prev. close | $4.04 | 52-week low | $1.82 |
| Day low | $4.03 | Volume | 1,811,500 |
| Day high | $4.15 | Avg. volume | 2,630,426 |
| 50-day MA | $4.30 | Dividend yield | N/A |
| 200-day MA | $3.46 | Market Cap | 748.45M |
Agenus Inc. (AGEN) Company Bio
Agenus Inc. engages in discovering and developing innovative treatments for patients with cancer and other diseases. The company was founded in 1994 and is based in Lexington, Massachusetts.
Loading social stream, please wait...